Afridi KS, Kaube H, Goadsby JP (2004) Glyceryl trinitrate triggers premonitory symptoms in migraineurs
For most, combining retatrutide with consistent physical activity has been an incremental journey, with its victories and bruises
Several GLP-1 agonists have FDA approval for other indications that may overlap with BED patient populations: Semaglutide (Wegovy) and liraglutide (Saxenda) are approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity Semaglutide (Ozempic), liraglutide (Victoza), dulaglutide (Trulicity), and tirzepatide (Mounjaro) are approved for type 2 diabetes management Tirzepatide (Zepbound) is approved for chronic weight management When clinicians prescribe GLP-1 agonists for BED, this constitutes off-label use a legal and common practice in medicine when evidence suggests potential benefit and approved treatments are inadequate
Mou QQ, He JX, Yan MJ, Wu CQ, Li XF, Li H
December 4, 2020
Dai S, Ye R, Huang J, Wang B, Xie Z, Ou X, Yu N, Huang C, Hua Y, Zhou R, Tian B
